Caryl E. Sortwell, Ph.D.

Translational Science & Molecular Medicine Michigan State University, East Lansing, MI 
Parkinson's disease therapeutics
"Caryl Sortwell"
Mean distance: 16.69 (cluster 19)
Cross-listing: Neuropathology Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Patterson JR, Cole-Strauss A, Kuhn N, et al. (2022) Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling. Journal of Visualized Experiments : Jove
Patterson JR, Hirst WD, Howe JW, et al. (2022) Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. Npj Parkinson's Disease. 8: 61
Sossi V, Patterson JR, McCormick S, et al. (2022) Dopaminergic Positron Emission Tomography Imaging in the Alpha-Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society
Jaehne EJ, Kent JN, Antolasic EJ, et al. (2022) Behavioral phenotyping of a rat model of the BDNF Val66Met polymorphism reveals selective impairment of fear memory. Translational Psychiatry. 12: 93
Sortwell CE, Hacker ML, Fischer DL, et al. (2021) BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease. Neuromodulation : Journal of the International Neuromodulation Society
Howe JW, Sortwell CE, Duffy MF, et al. (2021) Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein. Parkinsonism & Related Disorders. 89: 41-47
Miller KM, Mercado NM, Sortwell CE. (2021) Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor. Npj Parkinson's Disease. 7: 35
Landeck N, Conti Mazza M, Duffy M, et al. (2021) Stereotaxic Intracranial Delivery of Chemicals, Proteins or Viral Vectors to Study Parkinson's Disease. Journal of Visualized Experiments : Jove
Cole TA, Zhao H, Collier TJ, et al. (2021) α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease. Jci Insight. 6
Miller KM, Patterson JR, Kochmanski J, et al. (2021) Striatal afferent BDNF is disrupted by synucleinopathy and partially restored by STN DBS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
See more...